Page 90 - Comstock Act News Today

The supreme court is expected to rule on Friday on whether to uphold restrictions on mifepristone

Here's what to know about the case, how we got here, and what could be next.

Since Roe v. Wade, Republicans, by and large, want to bury their heads in the sand, hoping that nobody is really paying attention. But that’s not what’s happening. Millions of

U.S. Supreme Court could ban the practice on Friday.

Prior to the development of mifepristone, the FDA-approved abortion pill that is subject to a pending Supreme Court ruling, drug manufacturers like Chichester Chemical Co. sold women fake abortifacients through coded advertising. The company was based in Philadelphia, in present-day Graduate Hospital.

“No matter what laws and bans are out there, people are going to find a way to get access to the care that they need.”

The Supreme Court has left the case in the hands of the 5th U.S. Circuit Court of Appeals, which has scheduled oral arguments in the case for May 17.

In a brief filed with the state Supreme Court, Attorney General Raul Torres claims the cities and counties exceeded their authority by passing medical licensing rules that conflict with state provisions.

The Supreme Court has left the case in the hands of the 5th U.S. Circuit Court of Appeals, which has scheduled oral arguments in the case for May 17.

Here's what to know about the case, how we got here and what could be next.